Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 please find enclosed the press release titled Biocon and Mylan Announce U.S. FDA Approval of Semglee? (insulin glargine injection).
12-जून-2020
डाउनलोड पीडीएफ़
Biocon
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 please find enclosed the press release titled Biocon and Mylan Announce U.S. FDA Approval of Semglee? (insulin glargine injection).